ICER

The Institute for Clinical and Economic Review (ICER) is a trusted non-profit organization that evaluates evidence on the value of medical tests, treatments and delivery system innovations and moves that evidence into action to improve the health care system. To accomplish this goal ICER performs analyses on effectiveness and costs; develops reports using innovative methods that make it easier to translate evidence into decisions; and, most distinctively, fills a critical gap by creating sustainable initiatives with all health care stakeholders that can align efforts to use evidence to drive improvements in both practice and policy. Through all its work, ICER seeks to play a pivotal role in creating a future in which collaborative efforts to move evidence into action provide a foundation for a more effective, efficient, and just health care system.


ICER Weekly View 08-17-18

From the desk of Mitchell Stein Good morning. This week we launched a probe to the sun. No, not connected to this week’s newsletter, but how cool is that? Or how hot is that, which in this case may be more appropriate… Back in the pharmacy world, lots to talk […]


ICER Weekly View 08-10-18

From the desk of Mitchell Stein Good morning. I talk about randomized controlled trials a lot. Given the subject of this newsletter, that makes sense. This week, two items give us the opportunity for a great primer on the topic – see the first entry in Industry News below for […]


ICER Weekly View 08-03-18

From the desk of Mitchell Stein Good morning. On Twitter – what do you mean you’re not following me (@mhstein) on Twitter – there is a construct that goes something like “two things can be true at the same time” or “these two things are both true” or “it can […]


ICER Weekly View 07-27-18

From the desk of Mitchell Stein Good morning. I’m always fascinated by the early stages of a story when the narrative hasn’t quite jelled. That’s the case this week with Biogen/Eisai release of data on the study showing a benefit from their Alzheimer’s drug. Some publications were popping the champagne while […]


ICER Weekly View 07-20-18

From the desk of Mitchell Stein Good morning. I’m old enough to remember when policy proposals in DC slowed down during the summer. It was way back, like two or three years ago…  Whenever it was, it’s certainly not the case now with today’s 24/7 news cycle. The point was […]


ICER Weekly View 07-13-18

From the desk of Mitchell Stein Good morning. I’m trying to make this newsletter more streamlined – but, between taking a week off and so much drug pricing news, I fear I may have backslid a bit this week. I hope you can find it in your heart to forgive […]


ICER Weekly View 06-29-18

From the desk of Mitchell Stein Good morning. An editorial note. I won’t be publishing next week due to the July 4 holiday. Weekly View will return on Friday, July 13. Thank you Amazon – like many, I was a bit distracted this week by the flurry of disturbing news. […]


ICER Weekly View 06-22-18

From the desk of Mitchell Stein Good morning. There was a lot of non-pharma news this week. While that’s beyond the scope of our little newsletter, humor me as I share a mantra I learned from comedian Patton Oswalt: It’s chaos, be kind. You can’t go wrong following that advice. […]


ICER Weekly View 06-15-18

From the desk of Mitchell Stein Good morning. Today is both “Fly A Kite Day” and “Global Wind Day.” Seems appropriate they fall on the same day, doesn’t it? I hope everyone gets to enjoy a little outside time this weekend, remember it’s important to step away from the computer […]


ICER Weekly View 06-08-18

From the desk of Mitchell Stein Good morning. Congratulations to my DC readers on last night’s victory leading to the Capitals first Stanley Cup. As DC hockey fans you see vicious battles all the time, it must be nice to take a break from politics and watch peaceful ice hockey […]


ICER Weekly View 06-01-18

From the desk of Mitchell Stein Good morning. Before we get started today, I have a vitally important public service announcement for you. It’s national donut day! Here’s a list of all the chains participating. Remember, their offers apply to donuts, not donut holes. For now, donut holes are not […]


ICER Weekly View 05-25-18

From the desk of Mitchell Stein Good morning. Imagine a stone tossed in a pond whose ripples continue to spread weeks later, now imagine that stone is the President’s drug price speech. We’ll talk about the continued ripples emanating from that toss leading off today’s Inside the Beltway section. We’ll […]


ICER Weekly View 05-18-18

From the desk of Mitchell Stein Good morning. Drinking water from a fire hose – that’s the only way to describe trying to follow drug industry news this week. The President’s speech and elaboration from Azar and Gottlieb, approval of Aimovig, Ebola, biohacking and much more. I’m trying to keep […]


ICER Weekly View 05-11-18

From the desk of Mitchell Stein Good morning. The President will talk about prescription drug prices today (Friday). Last night, there was an off-the-record briefing of reporters on what will be included in the speech. We’ll take a look at what to expect in the Inside the Beltway section below […]


ICER Weekly View 05-04-18

From the desk of Mitchell Stein Good morning. First, my apologies for the delay in publishing this morning. Technical difficulties and all that. Second, before we dive into the week’s news let me wish you a Happy Star Wars Day. May the fourth be with you. (May the 4th, may […]


ICER Weekly View 04-27-18

From the desk of Mitchell Stein Good morning. Lots to cover today (isn’t there always), but first a public service announcement: Tomorrow (Saturday 4/28) is a national prescription drug take-back day. I’ve highlighted these in the past, but tomorrow’s promises to get more attention than ever as Google prepares to […]


ICER Weekly View 04-20-18

From the desk of Mitchell Stein Good morning. A busy week. starting with breakthrough lung cancer news out of American Association of Cancer Researchers conference (see Weekly View in-depth for details), news of an upcoming Presidential speech on drug pricing (See Inside the Beltway), and continuing developments in a potential […]


ICER Weekly View 04-13-18

From the desk of Mitchell Stein Good morning. I couldn’t decide how to lead off this morning… Do I write about today’s date? Do I write about how cold it still is? Do I pick out a favorite story to highlight? Since I can’t decide, let’s jump into the news. […]


ICER Weekly View 04-06-18

From the desk of Mitchell Stein Good morning. Before we get to the week’s news, let me tell you a story. Like many, I take a generic statin – my health insurer uses a PBM, and I order this maintenance drug through their mail order pharmacy. The cost of a […]


ICER Weekly View 03-30-18

From the desk of Mitchell Stein Good morning. I can’t help but lead with last night’s news that Walmart and Humana are talking about working more closely together, up to and including a purchase by Walmart of Humana. While reports indicate talks are in preliminary stages, the news caused a flurry […]